天堂国产午夜亚洲专区-少妇人妻综合久久蜜臀-国产成人户外露出视频在线-国产91传媒一区二区三区

當(dāng)前位置:主頁 > 醫(yī)學(xué)論文 > 心血管論文 >

荷丹片聯(lián)合阿托伐他汀治療冠心病的臨床研究

發(fā)布時間:2018-05-28 05:27

  本文選題:冠心病 + 荷丹片。 參考:《遼寧中醫(yī)雜志》2017年05期


【摘要】:目的:觀察荷丹片聯(lián)合阿托伐他汀治療冠心病的臨床治療效果以其為臨床診療提供參考。方法:分析2015年1月—2016年1月在我院接受診療的冠心病(穩(wěn)定性心絞痛)患者的資料。依據(jù)治療藥物的不同將患者分為觀察組(阿托伐他汀+荷丹片)及對照組(阿托伐他汀)。對比兩組患者治療期12個月內(nèi)心絞痛的累積發(fā)生率并檢測相關(guān)血液學(xué)指標(biāo)的改變。結(jié)果:本研究共納入觀察組41例,對照組44例。觀察組治療期間心絞痛的累積發(fā)生率顯著低于對照組(14.63%,6/41 vs 36.36%,16/44;Log-rankχ~2=5.619,P=0.018)。治療后,觀察組與對照組TC、TG、LDL-c水平均顯著降低(P0.05),但觀察組低于對照組患者(P0.05)。治療后,兩組患者治療后HDL-c水平均顯著升高(P0.05),但觀察組高于對照組患者(P0.05)。治療后,觀察組與對照組CRP、MMP-1、PAPP-A水平均顯著降低(P0.05),但觀察組低于對照組患者(P0.05)。結(jié)論:聯(lián)合使用荷丹片可顯著降低冠心病患者心絞痛發(fā)作頻率,可能與其調(diào)控血脂、抗炎及提高動脈粥樣斑塊穩(wěn)定等療效有關(guān)。
[Abstract]:Objective: to observe the clinical effect of Hedan tablet combined with Atto vastatin in the treatment of coronary heart disease. Methods: the data of patients with coronary heart disease (stable angina pectoris) treated in our hospital from January 2015 to January 2016 were analyzed. Patients were divided into observation group (Atto vastatin Hedan tablet) and control group (Atto vastatin). The cumulative incidence of angina pectoris and the changes of related hematologic indexes were compared between the two groups during 12 months. Results: the study included 41 cases in the observation group and 44 cases in the control group. The cumulative incidence of angina pectoris in the observation group was significantly lower than that in the control group (14.63 / 6 / 41 vs 36.36) during the treatment period. After treatment, the levels of TCU TGN LDL-c in both the observation group and the control group were significantly decreased, but the levels in the observation group were lower than those in the control group. After treatment, the level of HDL-c in the two groups was significantly higher than that in the control group, but the level of HDL-c in the observation group was higher than that in the control group. After treatment, the levels of MMP-1 and PAPP-A in the observation group and the control group decreased significantly, but the levels in the observation group were lower than those in the control group. Conclusion: combined use of Hedan tablet can significantly reduce the frequency of angina pectoris attack in patients with coronary heart disease, which may be related to its effect on regulating blood lipid, anti-inflammation and improving the stability of atherosclerotic plaque.
【作者單位】: 濟寧學(xué)院醫(yī)院;山東巨野煤田中心醫(yī)院;
【分類號】:R541.4

【相似文獻】

相關(guān)期刊論文 前2條

1 楊錫珍;楊國亮;苗少輝;徐洋;尹冬梅;;超聲評價荷丹片聯(lián)合阿托伐他汀治療頸動脈粥樣硬化的療效[J];河北醫(yī)藥;2013年18期

2 ;[J];;年期

,

本文編號:1945482

資料下載
論文發(fā)表

本文鏈接:http://sikaile.net/yixuelunwen/xxg/1945482.html


Copyright(c)文論論文網(wǎng)All Rights Reserved | 網(wǎng)站地圖 |

版權(quán)申明:資料由用戶b2f4f***提供,本站僅收錄摘要或目錄,作者需要刪除請E-mail郵箱bigeng88@qq.com